Literature DB >> 10426199

A clinicopathologic study of 196 intraoral minor salivary gland tumours.

M A Lopes1, L P Kowalski, G da Cunha Santos, O Paes de Almeida.   

Abstract

We present a retrospective study of 196 patients with intraoral minor salivary gland tumours, 128 malignant and 68 benign, diagnosed from 1954 to 1993 in the A. C. Camargo Hospital, São Paulo, Brazil. Sixty-five percent of the cases occurred in the palate, followed by tongue (9.7%) and retromolar area (6.1%). Pleomorphic adenoma was the most common benign tumour, and mucoepidermoid carcinoma was predominant among the malignant tumours. Surgery was the main treatment method and postoperative radiotherapy and radiotherapy alone were used in 40 and 15 patients, respectively. Local recurrence was observed in two patients with pleomorphic adenoma and in eight patients with malignant tumours. Regional lymph node metastases occurred in four cases and distant metastases in five. Forty-six of 47 patients with benign tumours who were followed up from 1 to 7 years were alive without disease. Twenty-four of 79 patients with malignant tumours who were followed up for at least 5 years died due the tumour and 47 were alive without disease.

Entities:  

Mesh:

Year:  1999        PMID: 10426199     DOI: 10.1111/j.1600-0714.1999.tb02036.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  21 in total

1.  Derived vascular endothelial cells induced by mucoepidermoid carcinoma cells: 3-dimensional collagen matrix model.

Authors:  Sen Yang; Li-juan Guo; Qing-hong Gao; Ming Xuan; Ke Tan; Qiang Zhang; Yu-ming Wen; Chang-mei Wang; Xiu-fa Tang; Xiao-yi Wang
Journal:  J Zhejiang Univ Sci B       Date:  2010-10       Impact factor: 3.066

2.  Transnasal endoscopic resection of a nasopharyngeal pleomorphic adenoma: a rare case report.

Authors:  Gabriel Martínez-Capoccioni; Carlos Martín-Martín; Federico Espinosa-Restrepo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-04-03       Impact factor: 2.503

3.  Malignant minor salivary gland tumors: a retrospective study of 27 cases.

Authors:  Astrid L D Kruse; Klaus W Grätz; Joachim A Obwegeser; Heinz-Theo Lübbers
Journal:  Oral Maxillofac Surg       Date:  2010-12

Review 4.  Extra-major salivary gland pleomorphic adenoma of the head and neck: a 10-year experience and review of the literature.

Authors:  Yen-Ling Kuo; Tzong-Yang Tu; Chia-Fan Chang; Wing-Yin Li; Shyue-Yih Chang; An-Suey Shiao; Pen-Yuan Chu; Kee-Tak Chan; Shyh-Kuan Tai; Yi-Fen Wang; Shu-Ching Kao; Shou-Yen Kao; Wen-Liang Lo; Cheng-Hsien Wu; Wen-Hu Shu; Shu Ma; Tien-Hsiang Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-12-01       Impact factor: 2.503

5.  Minor salivary gland tumors in the Indian population: A series of cases over a ten year period.

Authors:  Sonal Mishra; Y C Mishra
Journal:  J Oral Biol Craniofac Res       Date:  2014-11-22

6.  Pleomorphic adenoma of the submandibular gland: an evolving change in practice following review of a personal case series.

Authors:  Nazia Munir; Patrick J Bradley
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-05       Impact factor: 2.503

7.  Adenoid cystic carcinoma of the oral cavity: immunohistochemical study of four cases.

Authors:  Tadashi Terada
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

8.  Minor salivary gland tumours of upper aerodigestive tract: a clinicopathological study.

Authors:  Grażyna Wyszyńska-Pawelec; Michał Gontarz; Jan Zapała; Mariusz Szuta
Journal:  Gastroenterol Res Pract       Date:  2012-05-21       Impact factor: 2.260

9.  A clinico-pathologic study of 82 intraoral minor salivary gland tumors.

Authors:  Z Jaafari-Ashkavandi; M J Ashraf; N Afandak
Journal:  Iran Red Crescent Med J       Date:  2011-09-15       Impact factor: 0.611

10.  LINE-1 and Alu hypomethylation in mucoepidermoid carcinoma.

Authors:  Porntipa Sirivanichsuntorn; Somboon Keelawat; Kittipong Danuthai; Apiwat Mutirangura; Keskanya Subbalekha; Nakarin Kitkumthorn
Journal:  BMC Clin Pathol       Date:  2013-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.